{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:17:54Z","timestamp":1778649474878,"version":"3.51.4"},"reference-count":175,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mehy.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T13:23:34Z","timestamp":1445606614000},"page":"779-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Review of Amyotrophic Lateral Sclerosis, Parkinson\u2019s and Alzheimer\u2019s diseases helps further define pathology of the novel paradigm for Alzheimer\u2019s with heavy metals as primary disease cause"],"prefix":"10.1016","volume":"85","author":[{"given":"Franco","family":"Cavaleri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.10.009_b0005","author":"Cavaleri","year":"2015","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer\u2019s disease","volume":"143","author":"Ebneth","year":"1998","journal-title":"J Cell Biol"},{"issue":"6968","key":"10.1016\/j.mehy.2015.10.009_b0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02265","article-title":"Therapeutic approaches to protein-misfolding diseases","volume":"426","author":"Cohen","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbadis.2009.07.007","article-title":"Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"1802","author":"Devi","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbr.2004.04.012","article-title":"\u03b2-Amyloid (1\u201342)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex","volume":"155","author":"Jhoo","year":"2004","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0030","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1128\/MCB.01280-06","article-title":"Suppression of \u03b2-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65","volume":"27","author":"Bao","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0002-9440(10)63303-2","article-title":"Long-term accumulation of amyloid-\u03b2, \u03b2-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma","volume":"165","author":"Chen","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2015.10.009_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","author":"Ross","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(01)02254-6","article-title":"A novel presenilin mutation (M233V) causing very early onset Alzheimer\u2019s disease with Lewy bodies","volume":"313","author":"Houlden","year":"2001","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat Cell Biol"},{"issue":"6602","key":"10.1016\/j.mehy.2015.10.009_b0055","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-\u03b242 (43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat Med"},{"issue":"14","key":"10.1016\/j.mehy.2015.10.009_b0065","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1074\/jbc.M805685200","article-title":"Mutant presenilin 1 increases the expression and activity of BACE1","volume":"284","author":"Giliberto","year":"2009","journal-title":"J Biol Chem"},{"issue":"5646","key":"10.1016\/j.mehy.2015.10.009_b0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"J Clin Investig"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2015.10.009_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/NMM:4:1-2:21","article-title":"Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"4","author":"Hashimoto","year":"2003","journal-title":"NeuroMol Med"},{"issue":"5646","key":"10.1016\/j.mehy.2015.10.009_b0085","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.nbd.2011.12.002","article-title":"Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies","volume":"45","author":"Iguchi","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0100","doi-asserted-by":"crossref","first-page":"e1000193","DOI":"10.1371\/journal.pgen.1000193","article-title":"Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis","volume":"4","author":"Rutherford","year":"2008","journal-title":"PLoS Genet"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0105","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1074\/jbc.M409946200","article-title":"Metal-catalyzed oxidation of \u03b1-synuclein helping to define the relationship between oligomers, protofibrils, and filaments","volume":"280","author":"Cole","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/abbi.2000.1822","article-title":"Metal-catalyzed oxidation of \u03b1-synuclein in the presence of copper (II) and hydrogen peroxide","volume":"378","author":"Paik","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"5321","key":"10.1016\/j.mehy.2015.10.009_b0115","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0120","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper (II) binding to \u03b1-synuclein: insights into the bioinorganic chemistry of Parkinson\u2019s disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.mehy.2015.10.009_b0125","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of Alzheimer A\u03b2 by Cu (II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2015.10.009_b0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02820026","article-title":"Trace elements in Alzheimer\u2019s disease pituitary glands","volume":"62","author":"Cornett","year":"1998","journal-title":"Biol Trace Elem Res"},{"issue":"18","key":"10.1016\/j.mehy.2015.10.009_b0135","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M313572200","article-title":"Copper binding to the amyloid-\u03b2 (A\u03b2) peptide associated with Alzheimer\u2019s disease folding, coordination geometry, pH dependence, stoichiometry, and affinity of A\u03b2-(1\u201328): insights from a range of complementary spectroscopic techniques","volume":"279","author":"Syme","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/bi0358824","article-title":"Copper mediates dityrosine cross-linking of Alzheimer\u2019s amyloid-\u03b2","volume":"43","author":"Atwood","year":"2004","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.mehy.2015.10.009_b0145","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.M400805200","article-title":"Copper depletion down-regulates expression of the Alzheimer\u2019s disease amyloid-\u03b2 precursor protein gene","volume":"279","author":"Bellingham","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0150","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/\u03b1-synuclein in vitro","volume":"10","author":"Hashimoto","year":"1999","journal-title":"NeuroReport"},{"issue":"35","key":"10.1016\/j.mehy.2015.10.009_b0155","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1021\/ja803494v","article-title":"Site-specific interactions of Cu (II) with \u03b1 and \u03b2-synuclein: bridging the molecular gap between metal binding and aggregation","volume":"130","author":"Binolfi","year":"2008","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr Opin Chem Biol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2015.10.009_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","article-title":"Metals, oxidative stress and neurodegenerative disorders","volume":"345","author":"Jomova","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","article-title":"Human recombinant NACP\/\u03b1-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease","volume":"799","author":"Hashimoto","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.10.009_b0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.biochem.72.121801.161647","article-title":"Copper\u2013zinc superoxide dismutase and amyotrophic lateral sclerosis","volume":"74","author":"Valentine","year":"2005","journal-title":"Annu Rev Biochem"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0180","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1099\/00221287-148-11-3705","article-title":"Copper- and zinc-containing superoxide dismutase (Cu\/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence","volume":"148","author":"Hwang","year":"2002","journal-title":"Microbiology"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0185","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.93.12.5709","article-title":"A gain-of-function of an amyotrophic lateral sclerosis-associated Cu, Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide","volume":"93","author":"Yim","year":"1996","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1016-8478(23)13516-3","article-title":"Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu. Zn-superoxide dismutase mutants","volume":"9","author":"Eum","year":"1999","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1750-3639.1994.tb00811.x","article-title":"Oxygen radicals in focal cerebral ischemia","volume":"4","author":"Chan","year":"1994","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0200","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/nbdi.2000.0299","volume":"7","author":"Jaarsma","year":"2000","journal-title":"Neurobiol Dis"},{"issue":"39","key":"10.1016\/j.mehy.2015.10.009_b0205","doi-asserted-by":"crossref","first-page":"16398","DOI":"10.1073\/pnas.1102645108","article-title":"Intermolecular transmission of superoxide dismutase 1 misfolding in living cells","volume":"108","author":"Grad","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2003.12.004","article-title":"Disruption of the structure of the Golgi apparatus and the function of the secretory pathway by mutants G93A and G85R of Cu, Zn superoxide dismutase (SOD1) of familial amyotrophic lateral sclerosis","volume":"219","author":"Stieber","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mehy.2015.10.009_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/MI\/2006\/93684","article-title":"Glutamate receptors in neuroinflammatory demyelinating disease","volume":"2006","author":"Bolton","year":"2006","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.mehy.2015.10.009_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","author":"Foust","year":"2013","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0225","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1073\/pnas.1017275108","article-title":"Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells","volume":"108","author":"M\u00fcnch","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.mehy.2015.10.009_b0230","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1096\/fj.07-092783","article-title":"The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS","volume":"22","author":"Urushitani","year":"2008","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0235","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","article-title":"Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS","volume":"13","author":"Bosco","year":"2010","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1994.1107","article-title":"Secreted forms of \u03b2-amyloid precursor protein protect hippocampal neurons against amyloid \u03b2-peptide-induced oxidative injury","volume":"128","author":"Goodman","year":"1994","journal-title":"Exp Neurol"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0245","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0891-5849(01)00688-8","article-title":"Amyloid-\u03b2: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer\u2019s disease","volume":"31","author":"Kontush","year":"2001","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.mehy.2015.10.009_b0250","series-title":"Reactive oxygen species and the central nervous system, in Free Radicals in the Brain","author":"Halliwell","year":"1992"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0891-5849(99)00073-8","article-title":"Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction","volume":"27","author":"Liu","year":"1999","journal-title":"Free Radical Biol Med"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0260","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn2808","article-title":"Traumatic brain injury and amyloid-\u03b2 pathology: a link to Alzheimer\u2019s disease?","volume":"11","author":"Johnson","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0270","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1523\/JNEUROSCI.22-02-00446.2002","article-title":"Repetitive mild brain trauma accelerates A\u03b2 deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis","volume":"22","author":"Uryu","year":"2002","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0275","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1073\/pnas.122249699","article-title":"The galvanization of \u03b2-amyloid in Alzheimer\u2019s disease","volume":"99","author":"Bush","year":"2002","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"10.1016\/j.mehy.2015.10.009_b0280","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1021\/ic201233b","article-title":"Iron (II) binding to amyloid-\u03b2, the Alzheimer\u2019s peptide","volume":"50","author":"Bousejra-ElGarah","year":"2011","journal-title":"Inorg Chem"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0285","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper\u2013zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer\u2019s disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0290","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0304-3940(01)01876-6","article-title":"Intraneuronal A\u03b2 accumulation precedes plaque formation in \u03b2-amyloid precursor protein and presenilin-1 double-transgenic mice","volume":"306","author":"Wirths","year":"2001","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0295","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radical Biol Med"},{"issue":"19","key":"10.1016\/j.mehy.2015.10.009_b0300","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1073\/pnas.88.19.8362","article-title":"Effects of injected Alzheimer beta-amyloid cores in rat brain","volume":"88","author":"Frautschy","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2015.10.009_b0305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brainres.2007.01.070","article-title":"A\u03b2 peptides can enter the brain through a defective blood\u2013brain barrier and bind selectively to neurons","volume":"1142","author":"Clifford","year":"2007","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A [beta] oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2015.10.009_b0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/35004029","article-title":"The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant","volume":"2","author":"Goldstein","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0330","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","article-title":"Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?","volume":"45","author":"de Vries","year":"2008","journal-title":"Free Radical Biol Med"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0335","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","article-title":"Neuroprotective strategies involving ROS in Alzheimer disease","volume":"51","author":"Dumont","year":"2011","journal-title":"Free Radical Biol Med"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0340","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defence pathway: Keap1-dependent and-independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"10.1016\/j.mehy.2015.10.009_b0345","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M000361200","article-title":"Transcriptional regulation of the antioxidant response element Activation by Nrf2 and repression by MafK","volume":"275","author":"Nguyen","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0350","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-2011-110533","article-title":"S.H., et al., The BACE1-PSEN-A\u03b2PP regulatory axis has an ancient role in response to low oxygen\/oxidative stress","volume":"28","author":"Nik","year":"2012","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jnr.21461","article-title":"Alpha-synuclein and its role in metal binding: relevance to Parkinson\u2019s disease","volume":"86","author":"Wright","year":"2008","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0360","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","article-title":"Redox regulation of NF-kappa B activation","volume":"22","author":"Floh\u00e9","year":"1997","journal-title":"Free Radical Biol Med"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0365","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0026-895X(25)10539-7","volume":"48","author":"Garc\u00eda-Ruiz","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0370","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/jnr.21252","article-title":"Differential regulation of BACE1 promoter activity by nuclear factor-\u03baB in neurons and glia upon exposure to \u03b2-amyloid peptides","volume":"85","author":"Bourne","year":"2007","journal-title":"J Neurosci Res"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0375","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.bioeng.4.092801.094202","article-title":"Peptide aggregation in neurodegenerative disease","volume":"4","author":"Murphy","year":"2002","journal-title":"Annu Rev Biomed Eng"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0390","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-4159.1993.tb03639.x","article-title":"Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of \u03b2-amyloid peptide","volume":"61","author":"Mantyh","year":"1993","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0395","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0891-5849(00)00494-9","article-title":"Redox-active iron mediates amyloid-\u03b2 toxicity","volume":"30","author":"Rottkamp","year":"2001","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0400","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0039-9140(97)00218-X","article-title":"Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine","volume":"46","author":"Amrallah","year":"1998","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0405","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.mehy.2015.01.044","volume":"84","author":"Cavaleri","year":"2015","journal-title":"Med Hypotheses"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0410","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.57.6.808","article-title":"The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort","volume":"57","author":"Elias","year":"2000","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0415","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratic\u00f2","year":"2001","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0420","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"issue":"5594","key":"10.1016\/j.mehy.2015.10.009_b0425","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0430","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J Neuroinflam"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0435","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J Mol Med"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0440","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.emboj.7601953","article-title":"Lipids revert inert A\u03b2 amyloid fibrils to neurotoxic protofibrils that affect learning in mice","volume":"27","author":"Martins","year":"2008","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1471-4159.2000.0740231.x","article-title":"Mercury induces cell cytotoxicity and oxidative stress and increases \u03b2-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells","volume":"74","author":"Olivieri","year":"2000","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0450","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/eji.200940168","article-title":"Signaling by ROS drives inflammasome activation","volume":"40","author":"Martinon","year":"2010","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0455","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-6-41","article-title":"ER stress in Alzheimer\u2019s disease: a novel neuronal trigger for inflammation and Alzheimer\u2019s pathology","volume":"6","author":"Salminen","year":"2009","journal-title":"J Neuroinflam"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0460","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/abbi.1998.0813","article-title":"Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules","volume":"357","author":"Sengupta","year":"1998","journal-title":"Arch Biochem Biophys"},{"issue":"23","key":"10.1016\/j.mehy.2015.10.009_b0465","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr Med Chem"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0470","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1074\/jbc.R800030200","article-title":"Relevance of transgenic mouse models to human Alzheimer disease","volume":"284","author":"Morrissette","year":"2009","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0475","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156720506779025242","article-title":"Pathways by which A\u03b2 facilitates tau pathology","volume":"3","author":"Blurton-Jones","year":"2006","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI22317","article-title":"Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?","volume":"114","author":"Dickson","year":"2004","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0485","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.WNL.0000099372.75786.F8","article-title":"Microtubule-associated tau protein positive neuronal and glial inclusions in ALS","volume":"61","author":"Yang","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0490","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000218161.15834.db","article-title":"Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment","volume":"66","author":"Strong","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0495","first-page":"924","article-title":"Neurofibrillary degeneration in amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins","volume":"146","author":"Bu\u00e9e-Scherrer","year":"1995","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0500","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","article-title":"Disease-associated amyloid and misfolded protein aggregates activate the inflammasome","volume":"17","author":"Masters","year":"2011","journal-title":"Trends Mol Med"},{"issue":"4\u20135","key":"10.1016\/j.mehy.2015.10.009_b0505","first-page":"309","article-title":"Copper-dependent oxidative stress and neurodegeneration","volume":"50","author":"Rotilio","year":"2000","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0969-9961(03)00043-3","article-title":"Mitochondrial dysfunction due to mutant copper\/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine","volume":"13","author":"Beretta","year":"2003","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0515","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/pr.54.3.469","article-title":"Amyloid precursor protein, presenilins, and \u03b1-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer\u2019s disease","volume":"54","author":"Suh","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0520","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.mehy.2015.10.009_b0525","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson\u2019s disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0530","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an \u03b1-synuclein-overexpressing transgenic model of Parkinson\u2019s disease","volume":"33","author":"Haggerty","year":"2011","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0535","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2004.01.007","article-title":"More than just two peas in a pod: common amyloidogenic properties of tau and \u03b1-synuclein in neurodegenerative diseases","volume":"27","author":"Lee","year":"2004","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/IR:31:3:165","article-title":"Role of formyl peptide receptor-like 1 (FPRL1\/FPR2) in mononuclear phagocyte responses in Alzheimer disease","volume":"31","author":"Iribarren","year":"2005","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0545","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0550","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jnr.10393","article-title":"\u03b2-Secretase as a target for the treatment of Alzheimer\u2019s disease","volume":"70","author":"Citron","year":"2002","journal-title":"J Neurosci Res"},{"issue":"6930","key":"10.1016\/j.mehy.2015.10.009_b0555","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the \u03b3-secretase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0560","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.cellsig.2006.05.004","article-title":"ERK1\/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-\u03baB transactivation during oxidative stress in skeletal myoblasts","volume":"18","author":"Kefaloyianni","year":"2006","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0565","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1073\/pnas.91.5.1672","article-title":"Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1","volume":"91","author":"Schenk","year":"1994","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0570","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","article-title":"The role of NF-\u03baB in the regulation of cell stress responses","volume":"2","author":"Wang","year":"2002","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappaB in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.009_b0580","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J Neural Transm"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0585","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0197-4580(02)00034-9","article-title":"The role of microglia in Alzheimer\u2019s disease: friend or foe?","volume":"23","author":"Schenk","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0590","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","article-title":"Activation of microglia by aggregated \u03b2-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-\u03b3 and IL-4 render them protective","volume":"29","author":"Butovsky","year":"2005","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0595","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-\u0391\u03b2 antibodies reduce \u03b2-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J Neurosci"},{"issue":"6593","key":"10.1016\/j.mehy.2015.10.009_b0600","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","article-title":"Scavenger receptor-mediated adhesion of microglia to \u03b2-amyloid fibrils","volume":"382","author":"El Khoury","year":"1996","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0605","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","article-title":"Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein via a scavenger receptor","volume":"17","author":"Paresce","year":"1996","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0610","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.01-0530fje","article-title":"Microglial activation and amyloid-\u03b2 clearance induced by exogenous heat-shock proteins","volume":"16","author":"Kakimura","year":"2002","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0615","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0620","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","article-title":"CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to \u03b2-amyloid fibrils","volume":"160","author":"Coraci","year":"2002","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.mehy.2015.10.009_b0625","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1523\/JNEUROSCI.23-07-02665.2003","article-title":"A cell surface receptor complex for fibrillar \u03b2-amyloid mediates microglial activation","volume":"23","author":"Bamberger","year":"2003","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.mehy.2015.10.009_b0630","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.175.7.4320","article-title":"TLR signaling tailors innate immune responses in human microglia and astrocytes","volume":"175","author":"Jack","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0635","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1006\/bbrc.1994.2893","article-title":"Production of interleukin-10 by mouse glial cells in culture","volume":"205","author":"Mizuno","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0640","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.009_b0645","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","article-title":"Synuclein activates microglia in a model of Parkinson\u2019s disease","volume":"29","author":"Su","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0650","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","article-title":"Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line","volume":"69","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurosci Res"},{"issue":"6645","key":"10.1016\/j.mehy.2015.10.009_b0655","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.142.2.549","article-title":"IL-1 stimulates IL-6 production in endothelial cells","volume":"142","author":"Sironi","year":"1989","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.009_b0665","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","article-title":"Blocking IL-1 in systemic inflammation","volume":"201","author":"Dinarello","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0670","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12","volume":"177","author":"Hamerman","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0675","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0680","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/glia.10153","article-title":"Microglia and inflammatory mechanisms in the clearance of amyloid \u03b2 peptide","volume":"40","author":"Rogers","year":"2002","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0685","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J Neuroinflam"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0690","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.009_b0695","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0700","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","article-title":"TREM and TREM-like receptors in inflammation and disease","volume":"21","author":"Ford","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.mehy.2015.10.009_b0705","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2013.06.003","article-title":"Sex steroid hormone-mediated functional regulation of microglia-like BV-2 cells during hypoxia","volume":"138","author":"Habib","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0710","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1172\/JCI30602","article-title":"TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases","volume":"117","author":"Schenk","year":"2007","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0715","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.gastro.2012.10.040","article-title":"Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response","volume":"144","author":"C.","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0720","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4161\/self.1.3.12891","article-title":"Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases","volume":"1","author":"Derive","year":"2010","journal-title":"Self Nonself"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0725","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.mehy.2015.10.009_b0730","doi-asserted-by":"crossref","unstructured":"Leibbrandt A, Penninger JM, RANKL\/RANK as key factors for osteoclast development and bone loss in arthropathies, in: Molecular Mechanisms of Spondyloarthropathies. Springer. 2009. p. 100\u201313.","DOI":"10.1007\/978-1-4419-0298-6_7"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0735","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0740","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U","article-title":"Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family","volume":"31","author":"Daws","year":"2001","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0745","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","article-title":"Variant TREM2 as risk factor for Alzheimer\u2019s disease","volume":"368","author":"Neumann","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2015.10.009_b0750","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p. R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0755","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/neu.2008.0655","article-title":"Role of Nrf2 in protection against traumatic brain injury in mice","volume":"26","author":"Jin","year":"2009","journal-title":"J Neurotrauma"},{"issue":"01","key":"10.1016\/j.mehy.2015.10.009_b0760","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2015.10.009_b0765","series-title":"Dropping the BACE: beta secretase (BACE1) as an Alzheimer\u2019s disease intervention target. Neurodegenerative diseases","author":"Read","year":"2013"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0770","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0775","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-4159.2009.06130.x","article-title":"The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor","volume":"110","author":"Stefano","year":"2009","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0780","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1044-7431(03)00227-6","article-title":"BACE1 (\u03b2-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0785","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"20","key":"10.1016\/j.mehy.2015.10.009_b0790","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.107.731877","article-title":"Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis","volume":"117","author":"Ikonomidis","year":"2008","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.mehy.2015.10.009_b0795","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study","volume":"288","author":"Zandi","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.009_b0800","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1541-4337.2010.00129.x","article-title":"Microbial risks associated with cabbage, carrots, celery, onions, and deli salads made with these produce items","volume":"9","author":"Erickson","year":"2010","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"26","key":"10.1016\/j.mehy.2015.10.009_b0805","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1523\/JNEUROSCI.0886-13.2013","article-title":"Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ER\u03b1 signaling on astrocytes but not through ER\u03b2 signaling on astrocytes or neurons","volume":"33","author":"Spence","year":"2013","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0810","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1046\/j.1471-4159.2000.0751447.x","article-title":"Estrogen enhances uptake of amyloid \u03b2-protein by microglia derived from the human cortex","volume":"75","author":"Li","year":"2000","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.009_b0815","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archneur.64.5.683","article-title":"Testosterone treatment in multiple sclerosis: a pilot study","volume":"64","author":"Sicotte","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2015.10.009_b0820","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0079-6123(09)17516-7","article-title":"Estrogen and testosterone therapies in multiple sclerosis","volume":"175","author":"Gold","year":"2009","journal-title":"Prog Brain Res"},{"issue":"38","key":"10.1016\/j.mehy.2015.10.009_b0825","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.1212-08.2008","article-title":"Growth of white matter in the adolescent brain: role of testosterone and androgen receptor","volume":"28","author":"Perrin","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0830","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00222891003697921","article-title":"Neuroprotective effects of testosterone on regenerating spinal cord motoneurons in rats","volume":"42","author":"Tehranipour","year":"2010","journal-title":"J Mot Behav"},{"issue":"36","key":"10.1016\/j.mehy.2015.10.009_b0835","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1523\/JNEUROSCI.2796-12.2012","article-title":"Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease","volume":"32","author":"Ziehn","year":"2012","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0840","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/brain\/aws284","article-title":"The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination","volume":"136","author":"Hussain","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.009_b0845","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/014107689208501008","article-title":"A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle","volume":"85","author":"Smith","year":"1992","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.009_b0850","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","article-title":"Neuroinflammation mediated by IL-1\u03b2 increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease","volume":"5","author":"Koprich","year":"2008","journal-title":"J Neuroinflam"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.009_b0855","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/kel041","article-title":"Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)","volume":"45","author":"Vounotrypidis","year":"2006","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0860","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.jcbfm.9600537","article-title":"Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations","volume":"28","author":"Clark","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.009_b0865","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/jcbfm.2010.103","article-title":"Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study","volume":"31","author":"Galea","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.009_b0870","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lfs.2007.07.003","article-title":"Antihyperalgesic effects induced by the IL-1 receptor antagonist anakinra and increased IL-1\u03b2 levels in inflamed and osteosarcoma-bearing mice","volume":"81","author":"Baamonde","year":"2007","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.009_b0875","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF00254490","article-title":"Transport of nutrients and hormones through the blood\u2013brain barrier","volume":"20","author":"Pardridge","year":"1981","journal-title":"Diabetologia"}],"updated-by":[{"DOI":"10.1016\/j.mehy.2016.10.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000}}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:18:10Z","timestamp":1759691890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":175,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0306987715003801"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.10.009","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Amyotrophic Lateral Sclerosis, Parkinson\u2019s and Alzheimer\u2019s diseases helps further define pathology of the novel paradigm for Alzheimer\u2019s with heavy metals as primary disease cause","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}